salvia Report issue

Botanical Experimental
AACT DrugBank PubChem

Active Ingredient History

NOW
  • Now
Salvia is the largest genus of plants in the sage family Lamiaceae, with nearly 1000 species of shrubs, herbaceous perennials, and annuals. Within the Lamiaceae, Salvia is part of the tribe Mentheae within the subfamily Nepetoideae. One of several genera commonly referred to as sage, it includes two widely used herbs, Salvia officinalis and Salvia rosmarinus.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

sage | sage leaf allergenic extract | salvia | salvia hispanica | salvia hispanica l. | salvia miltiorrhiza extract | salvia officinalis | salvia sample

Organizations (40)

Research & Development (40)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (9)

Approved Indications (1)


 

Seizures

Experimental Indications - Clinical Trial Phases 1-4 (9)


 

Altitude Sickness (Phase 3)

Alzheimer Disease (Phase 1)

Angina Pectoris (Phase 3)

COVID-19 (Phase 2/Phase 3)

Hyperuricemia (Phase 4)

Pharyngitis (Phase 3)

Respiratory Tract Infections (Phase 2/Phase 3)

Seizures ()

Virus Diseases (Phase 2/Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 20
  • # of Trial Organizations: 40

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue